Cargando…
Contribution of Flexig mobile application to assess adherence of patients treated with immunoglobulins in chronic diseases
BACKGROUND: Long-term therapeutic adherence remains an essential challenge for better management of chronic diseases. It is estimated at 50% in developed countries. OBJECTIVE: The study aimed to evaluate, under real conditions, the influence of satisfaction with Flexig use on adherence to subcutaneo...
Autores principales: | Pindi Sala, Taylor, Matondo Masisa, Daniel, Crave, Jean Charles, Belmokhtar, Chafke, LeNy, Guillaume, Situakibanza, Hippolyte, Duracinsky, Martin, Cherin, Patrick, Chassany, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616388/ https://www.ncbi.nlm.nih.gov/pubmed/37915723 http://dx.doi.org/10.1016/j.jacig.2023.100173 |
Ejemplares similares
-
Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study
por: Chérin, Patrick, et al.
Publicado: (2020) -
High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis
por: Patrick, Cherin, et al.
Publicado: (2014) -
Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
por: Cherin, Patrick, et al.
Publicado: (2015) -
Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases
por: Cherin, Patrick, et al.
Publicado: (2015) -
In-depth interviews of patients with primary immunodeficiency who have experienced pump and rapid push subcutaneous infusions of immunoglobulins reveal new insights on their preference and expectations
por: Cozon, Grégoire Jacques Noël, et al.
Publicado: (2018)